3 results loaded, newest first. End of these results.
News 2026-10-07 12:10 UTC
Oct 7 (Reuters) — Azenta, Inc.: Azenta - Approves Restructuring Plan Within Multiomics Segment On October 5, 2026 - Sec Filing Azenta - Plan Includes Workforce Reductions And Closure Of Three Multiomics Lab Sites In North America - Sec Filing Azenta - Estimates Aggregate Pre-tax Charges Of $11 Million-$13 Million From
News 2026-10-07 12:07 UTC
Azenta said it approved a restructuring plan within its Multiomics segment effective October 5, 2026.
News 2026-10-07 12:05 UTC
Azenta said its board approved a restructuring plan in its Multiomics segment that includes workforce reductions and the closure of three North American laboratory sites. The company expects about $11 million to $13 million in pre-tax charges and about $11 million in annualized cost savings once fully implemented.